We measure success by our impact on the patients we serve
Caring Deeply. Changing Lives.
Biogen is one of the world’s leading biotechnology companies, with a focus on developing therapies for serious neurological, autoimmune and rare diseases. Founded in 1978, our work in biologics and small-molecule drug discovery has led to the world’s most extensive portfolio of multiple sclerosis therapies and innovative new treatments for haemophilia patients. Our experience, capabilities and passion for innovation have enabled us to build a pipeline and develop advanced research programmes that include exploration of potential candidates for serious and difficult-to-treat neurodegenerative diseases and fibrotic and nonmalignant blood disorders.
We are committed to research that uncovers the underlying biology of complex diseases. Our focus is on illnesses with few, if any, treatment options. Biogen’s success will always be measured by the answer to a simple question: Have we truly made a difference in the lives of patients?
Biogen is committed to making a positive impact on the world by developing medicines that help patients around the globe, creating a supportive environment for our employees, minimising our carbon footprint, investing in science education and giving back to our local communities.
Science is the core of our work. Our research sheds new light on complex diseases and leads to therapies that can improve patients’ lives. Biogen researchers have developed leading treatments for multiple sclerosis and provided significant advances in the treatment of haemophilia A and haemophilia B.
We work to ensure that patients can access our therapies through assistance and support programmes and through our work with patient advocates and regulatory agencies.
ENHANCING THE WORKPLACE
We believe that equality and diversity are crucial to a positive work environment. We promote a more inclusive culture by continuously engaging with employees. In 2015, we achieved a perfect score of 100 on the Human Rights Campaign Corporate Equality Index, and are frequently named by influential publications as being among the best places to work.
We are committed to environmental sustainability. In 2015, the Corporate Knights ranked Biogen as the most sustainable company in the world. The same year, Biogen was also named the biotechnology industry leader on the Dow Jones Sustainability World Index for the second year in a row, after becoming the first U.S.-based biotech company to make the list in 2013. The company was also named to the Dow Jones Sustainability Index North America for the sixth consecutive year, one of only three biotech companies included.
NURTURING STEM EDUCATION
Future discoveries in biotechnology depend on bolstering the scientific literacy of students today. Our Biogen Foundation is creating global initiatives in STEM subjects (science, technology, engineering and mathematics) for students of every age — from young learners to those pursuing careers in life sciences.
We strive to be a good neighbour in all of our corporate locations. Our “micro-grants” support science-oriented programmes and activities globally. We also contribute to programs and institutions that provide our local communities with resources, and develop programmes that enable and encourage our employees to engage in local communities.